echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > PNAS: Compounds in the apple skin can reverse neuronal damage in multiple sclerosis

    PNAS: Compounds in the apple skin can reverse neuronal damage in multiple sclerosis

    • Last Update: 2020-05-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Multiple sclerosis (MS) is characterized by muscle weakness and increased paralysis, and a variety of therapies can help slow the progression of the disease at an early stage, but it is difficult to reverse the damage that has occurred in neuronsA new study in PNAS suggests that bear palicacid, a compound found in fruits such as apples and plums, and some herbs can reduce further damage to neurons and help rebuild the protective palate that covers neurons, thus reversing the damageresearchers experimented using laboratory-grade sascoic acid purified, using an established mouse model of multiple sclerosis, EAE, that mimics human disease, slowly developing disease during its life, and that around the 12th day, when signs of MS, partial paralysis, and the most effective drugs currently available, the mice begin the acute phase of the diseaseresearchers began treating mice at the end of the 60th day, when the brain and spinal cord developed chronic tissue damage that needed to be repaired and regeneratedOn the 20th day of treatment, the paralysed mice recovered to walk after treatment, albeit weakThe researchers say that while this is not a cure, if a similar response is seen in humans, it will represent a significant change in quality of lifeAnd most importantly, it's a reversal that's never seen at such a late stagebear palaenic acid therapy can alleviate chronic EAE, promote myelin regeneration and reduce axial mutation and neuronal dendritic damage
    in addition, the researchers also studied how bear palaeontine acid acts on cells, and they observed that it inhibits Th17 cells, an immune cell that is one of the main drivers of MS's pathological autoimmune responseMany therapies now seem to inhibit Th17, but the compound activates precursor cells and matures them into much-needed myelin-producing cells, i.efewer glial cellsThis maturation is the most critical, MS in the manufacture of myelin less protrusive glial cells exhausted, and the production of new less protoscoction cells stem cells in a dormant state, unable to matureThe compound helps activate these stem cells and may be the cause of the reversal of symptomsthe eAE immunomodulation and neuroregeneration models mediated by bear fruit acidit is encouraging to see in the laboratory that a compound can both stop and repair damage from multiple diseases, although the evidence from animal disease models is preliminaryThe next step for researchers to test the safety of compounds, which still has many tests to complete before the first clinical trial, is a great precursor to the treatment of disease
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.